US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist
  • 15.130
  • 0.0000.00%
Trading May 17 16:00 ET
223.75MMarket Cap1.09P/E (TTM)

Merrimack Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.16%669K
0.09%2.18M
-19.28%490K
5.36%531K
17.08%569K
1.56%586K
-16.90%2.17M
28.33%607K
-18.58%504K
-37.53%486K
Selling and administrative expenses
14.16%669K
0.09%2.18M
-19.28%490K
5.36%531K
17.08%569K
1.56%586K
-16.90%2.17M
28.33%607K
-18.58%504K
-37.53%486K
-General and administrative expense
14.16%669K
0.09%2.18M
-19.28%490K
5.36%531K
17.08%569K
1.56%586K
-16.90%2.17M
28.33%607K
-18.58%504K
-37.53%486K
Operating profit
-14.16%-669K
-0.09%-2.18M
19.28%-490K
-5.36%-531K
-17.08%-569K
-1.56%-586K
16.90%-2.17M
-28.33%-607K
18.58%-504K
37.53%-486K
Net non-operating interest income expense
32.39%233K
361.70%868K
122.03%262K
306.45%252K
2,125.00%178K
176K
840.00%188K
11,700.00%118K
62K
-57.89%8K
Non-operating interest income
32.39%233K
361.70%868K
122.03%262K
306.45%252K
2,125.00%178K
--176K
840.00%188K
11,700.00%118K
--62K
-57.89%8K
Other net income (expense)
-68.76%139K
0
-68.76%139K
209.03%445K
0
Special income (charges)
--0
-68.76%139K
--0
--0
--0
-68.76%139K
209.03%445K
--0
--0
--0
-Gain on sale of property,plant,equipment
--0
-68.76%139K
----
----
----
-68.76%139K
209.03%445K
----
----
----
Income before tax
-60.89%-436K
24.14%-1.17M
53.37%-228K
36.88%-279K
18.20%-391K
-105.30%-271K
37.15%-1.54M
-3.60%-489K
15.81%-442K
37.02%-478K
Income tax
300.00%12K
0.00%3K
Net income
74,406.27%201.37M
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
Net income continuous Operations
-60.89%-436K
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
Net income discontinuous operations
--201.81M
----
----
----
----
--0
----
----
----
----
Minority interest income
Net income attributable to the parent company
74,406.27%201.37M
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
74,406.27%201.37M
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
Basic earnings per share
69,750.00%13.93
27.27%-0.08
66.67%-0.01
33.33%-0.02
25.00%-0.03
-100.00%-0.02
38.89%-0.11
0.00%-0.03
25.00%-0.03
33.33%-0.04
Diluted earnings per share
69,750.00%13.93
27.27%-0.08
66.67%-0.01
33.33%-0.02
25.00%-0.03
-100.00%-0.02
38.89%-0.11
0.00%-0.03
25.00%-0.03
33.33%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.16%669K0.09%2.18M-19.28%490K5.36%531K17.08%569K1.56%586K-16.90%2.17M28.33%607K-18.58%504K-37.53%486K
Selling and administrative expenses 14.16%669K0.09%2.18M-19.28%490K5.36%531K17.08%569K1.56%586K-16.90%2.17M28.33%607K-18.58%504K-37.53%486K
-General and administrative expense 14.16%669K0.09%2.18M-19.28%490K5.36%531K17.08%569K1.56%586K-16.90%2.17M28.33%607K-18.58%504K-37.53%486K
Operating profit -14.16%-669K-0.09%-2.18M19.28%-490K-5.36%-531K-17.08%-569K-1.56%-586K16.90%-2.17M-28.33%-607K18.58%-504K37.53%-486K
Net non-operating interest income expense 32.39%233K361.70%868K122.03%262K306.45%252K2,125.00%178K176K840.00%188K11,700.00%118K62K-57.89%8K
Non-operating interest income 32.39%233K361.70%868K122.03%262K306.45%252K2,125.00%178K--176K840.00%188K11,700.00%118K--62K-57.89%8K
Other net income (expense) -68.76%139K0-68.76%139K209.03%445K0
Special income (charges) --0-68.76%139K--0--0--0-68.76%139K209.03%445K--0--0--0
-Gain on sale of property,plant,equipment --0-68.76%139K-------------68.76%139K209.03%445K------------
Income before tax -60.89%-436K24.14%-1.17M53.37%-228K36.88%-279K18.20%-391K-105.30%-271K37.15%-1.54M-3.60%-489K15.81%-442K37.02%-478K
Income tax 300.00%12K0.00%3K
Net income 74,406.27%201.37M23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K
Net income continuous Operations -60.89%-436K23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K
Net income discontinuous operations --201.81M------------------0----------------
Minority interest income
Net income attributable to the parent company 74,406.27%201.37M23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 74,406.27%201.37M23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K
Basic earnings per share 69,750.00%13.9327.27%-0.0866.67%-0.0133.33%-0.0225.00%-0.03-100.00%-0.0238.89%-0.110.00%-0.0325.00%-0.0333.33%-0.04
Diluted earnings per share 69,750.00%13.9327.27%-0.0866.67%-0.0133.33%-0.0225.00%-0.03-100.00%-0.0238.89%-0.110.00%-0.0325.00%-0.0333.33%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data